Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Expedia Group, Inc. operates as an online travel company worldwide.
Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally.
Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the United States.
Marriott International, Inc. operates, franchises, and licenses hotel, residential, and timeshare properties worldwide.
Snap Inc. operates as a camera company in the United States and internationally.
Sea Limited engages in the digital entertainment, e-commerce, and digital financial service businesses in Southeast Asia, Latin America, rest of Asia, and internationally.
NIO Limited designs, manufactures, and sells electric vehicles in the People’s Republic of China, Hong Kong, the United States, the United Kingdom, and Germany.
Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America.
ZoomInfo Technologies Inc. operates cloud-based go-to-market intelligence platform for sales and marketing teams in the United States and internationally.
Booking Holdings Inc. provides travel and restaurant online reservation and related services worldwide.
XP Inc. operates technology-driven financial services platform that provides financial products and services in Brazil.
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, Netherlands, Norway, and internationally.
Enphase Energy, Inc., together with its subsidiaries, designs, develops, manufactures, and sells home energy solutions for the solar photovoltaic industry in the United States and internationally.
Pinduoduo Inc., through its subsidiaries, operates an e-commerce platform in the People's Republic of China.
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases.
SolarEdge Technologies, Inc., together with its subsidiaries, designs, develops, and sells direct current (DC) optimized inverter systems for solar photovoltaic (PV) installations worldwide.